Piroctone olamine disrupts mitochondrial dynamics in glioma cells through the PI3K/AKT pathway.
10.12122/j.issn.1673-4254.2023.05.12
- Author:
Wenqin XU
1
;
Jingjing YE
1
;
Fei WANG
2
;
Tianbing CHEN
1
Author Information
1. Key Laboratory of Noncoding RNA Transformation Research of Anhui Higher Education Institution, Wannan Medical College, Wuhu 241002, China.
2. Wuhu Hospital of Traditional Chinese Medicine, Wuhu 241001, China.
- Publication Type:Journal Article
- Keywords:
PI3K/AKT pathway;
glioma;
mitochondrial fission;
piroctone olamine
- MeSH:
Humans;
Glioma;
Mitochondrial Dynamics;
Phosphatidylinositol 3-Kinases;
Proto-Oncogene Proteins c-akt
- From:
Journal of Southern Medical University
2023;43(5):764-771
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the growth-inhibitory and pro-apoptotic effects of piroctone olamine (PO) on glioma cells and explore the underlying mechanism.
METHODS:Human glioma cell lines U251 and U373 were treated with PO and the changes in cell proliferation were detected using CCK-8 assay and EdU assay. Clone formation assay and flow cytometry were used to examine the changes in clone formation ability and apoptosis of the treated cells. Mitochondrial membrane potential of the cells and morphological changes of the mitochondria were detected using JC-1 staining and a fluorescence probe, respectively. The expressions of mitochondrial fission protein DRP1 and the fusion protein OPA1 were determined with Western blotting. Transcriptome sequencing and differential gene enrichment analysis was performed, and the expression levels of PI3K, AKT and p-AKT in the treated cells were verified using Western blotting.
RESULTS:CCK-8 assay showed that PO significantly inhibited the proliferation of U251 and U373 cells in a time- and dose-dependent manner (P < 0.001). EdU test showed that the proliferative activity of PO-treated cells was significantly decreased, and the number of cell colonies also decreased significantly (P < 0.01). PO treatment significantly increased apoptotic rates (P < 0.01), decreased mitochondrial membrane potential and caused obvious changes in mitochondrial morphology of the cells. Pathway enrichment analysis showed that the down-regulated genes were significantly enriched in the PI3K/AKT pathway, which was verified by Western blotting showing significantly down-regulated expression levels of PI3K, AKT and p-AKT in PO-treated cells (P < 0.05).
CONCLUSION:PO interferes with mitochondrial fusion and fission function through the PI3K/AKT pathway, thereby inhibiting the proliferation and increasing apoptosis of glioma cells.